Superstring Capital Management LP is a New York-based healthcare-dedicated investment firm focused on public and private investments in pharmaceutical/biotech, medtech and healthcare services globally. Our team is comprised of life sciences investment specialists trained at the world’s preeminent academic and business institutions with significant biopharma industry experience. Backed by a long-term global institutional capital base consisting of university endowments, sovereign wealth funds, medical foundations and family offices, Superstring seeks to leverage its in-depth industry, commercial and regulatory knowledge to collaborate with portfolio companies as a trusted long-term partner.